QDEL
- QuidelOrtho Corporation
()
Overview
Company Summary
QuidelOrtho Corporation, commonly known as QDEL, is a biotechnology company primarily engaged in the development, manufacturing, and sale of diagnostic healthcare products. The company specializes in creating rapid diagnostic testing solutions that aid in the detection and diagnosis of various medical conditions.
QDEL's core expertise lies in producing diagnostic assays, instruments, and related products that focus on detecting infectious diseases, gastrointestinal diseases, women's health issues, and certain autoimmune disorders. They provide solutions that enable healthcare professionals to quickly and accurately identify the presence or absence of specific pathogens or substances in patient samples.
The company offers a range of diagnostic platforms, including lateral flow assays, fluorescent immunoassays, and molecular diagnostic tests. These testing methods allow for rapid and precise diagnosis, empowering healthcare providers to make informed treatment decisions promptly.
QuidelOrtho serves a wide range of customers, including hospitals, clinics, physicians' offices, reference laboratories, and retail and urgent care settings. Their products cater to various healthcare disciplines, such as respiratory, sexual, and gastrointestinal health.
In addition to diagnostic testing products, QDEL also provides customer support services, including technical assistance, training, and maintenance services for their instruments and assays. They prioritize innovation and actively invest in research and development to drive advancements in diagnostic testing technologies.
Overall, QuidelOrtho Corporation plays a significant role in enhancing patient care by offering efficient and reliable diagnostic testing solutions to aid in the timely detection and management of medical conditions.